“…NANPs’ ability to successfully combat diseases at their source has already been confirmed by multiple animal studies [25,38,39,40,41,42,43]. Additionally, the design principles being developed in RNA nanotechnology address fundamental problems relevant to the biophysics of RNA co-transcriptional folding [24,44,45,46,47], structure–activity relationships [48], and their physicochemical interactions with other classes of biomolecules (e.g., lipids [41,49,50], proteins [51,52]) or inorganic materials [53,54].…”